ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Aptus Pharma Limited submitted the Regulation 74(5) compliance certificate for the quarter and half-year ended 30th September 2026, as received from its registrar.
Aptus Pharma Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with SEBI regulatory requirements.
Aptus Pharma Ltd informed BSE that Regulation 24A of SEBI (LODR) Regulations, 2015, regarding the Annual Secretarial Compliance Report, is not applicable to the company. As an entity listed on the SME Exchange, it falls under the exemptions provided in Regulation 15(2)(b).